Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

Katsutoshi Sekine, Shintaro Kanda, Yasushi Goto, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Noriko Motoi, Yuichiro Ohe

Lung Cancer · 2018 · 78 citations · 25 references

DOIFull text

Open access

Concepts

References

25